Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05024136
Other study ID # CS1-20030
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 20, 2021
Est. completion date March 2023

Study information

Verified date June 2022
Source Chung Shan Medical University
Contact You-Cheng Mr Shen, Ph.D.
Phone 886-4-24730022
Email youcheng@csmu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, subjects with depression/anxiety inhaled the essential oil, which contained sedative, soothing, and relaxing active ingredients to stimulate the olfactory nerve. The essential oil further transmitted to the limbic system that controls emotions in the brain, and then affected the human's mood. The natural aroma can not only awaken the limbic system's memory of aroma but also reflect the subconscious area of the brain, with physiological changes (such as controlling blood pressure, breathing, heartbeat, stress changes, memory, and hormonal coordination.) This study monitors the subject's autonomic nerve parameters before and after aromatherapy to obtain the olfactory cerebral nervous system to convey the message. When the study finishes, we expected to help the subject to relax and soothe the mind.


Description:

Subjects receive three times 30 mins aromatherapy of Limon or Vetiver essential oil per time for the month. Anthropometric measurements such as blood pressure (systolic blood pressure [SBP] and diastolic blood pressure [DBP]), autonomic nerve parameters including a. SDNN (standard deviation of all normal to normal intervals index); b. HRV(heart rate variability); c. LF(0.04-0.15 Hz)and HF(0.15-0.4 Hz)were measured every week. PSQI(Pittsburgh sleep quality index)and HADS (Hospital Anxiety and Depression Scale) were measured initial and ten ends.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date March 2023
Est. primary completion date October 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: 1. Depressed/anxious people (diagnosed as a single episode of major depression, recurrence of major depression, mild depression, panic disorder, and anxiety.) Those diagnosed with symptoms of depression, and anxiety related to stress adjustment disorder, and willing to cooperate with the study. 2. Age 20-65 years old Exclusion Criteria: 1. an alcoholic 2. Uncontrolled diabetes 3. Those who have had a stroke in the last year 4. Pregnant and lactating women 5. People with liver or heart disease 6. Arrhythmia or those with a heart rhythm regulator 7. Those whose heart has already been fitted with a cardiac catheter stent 8. Those who have used central nervous system stimulants (regardless of the length of time) 9. Those who are allergic to essential oils 10. Those who have used aromatherapy within a month 11. Subjects request to withdraw from the trial 12. The host feels unsuitable to continue the study

Study Design


Intervention

Device:
Limon essential oil aromatherapy
Subjects receive three times 30 mins aromatherapy of Limon essential oil per time for the month. Anthropometric measurements such as blood pressure (systolic blood pressure [SBP] and diastolic blood pressure [DBP]), autonomic nerve parameters including a. SDNN (standard deviation of all normal to normal intervals index); b. HRV(heart rate variability); c. LF(0.04-0.15 Hz)and HF(0.15-0.4 Hz)were measured every week. PSQI(Pittsburgh sleep quality index)and HADS (Hospital Anxiety and Depression Scale) were measured initial and ten ends.
Vetiver essential oil aromatherapy
Subjects receive three times 30 mins aromatherapy of vetiver essential oil per time for the month. Anthropometric measurements such as blood pressure (systolic blood pressure [SBP] and diastolic blood pressure [DBP]), autonomic nerve parameters including a. SDNN (standard deviation of all normal to normal intervals index); b. HRV(heart rate variability); c. LF(0.04-0.15 Hz)and HF(0.15-0.4 Hz)were measured every week. PSQI(Pittsburgh sleep quality index)and HADS (Hospital Anxiety and Depression Scale) were measured initial and ten ends.

Locations

Country Name City State
Taiwan Chung Shan Medical University Taichung

Sponsors (1)

Lead Sponsor Collaborator
Chung Shan Medical University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary The aromatherapy measure autonomic nerve parameter SDNN (standard deviation of all normal to normal intervals index) one month
Primary The measure blood pressure (SBP and DBP) values change of systolic and diastolic BPs one month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06406595 - Hemispheric Asymmetries in Emotion-Cognition Interactions
Not yet recruiting NCT06112457 - Anxiety and Depression Among Gendarmes Posted to French Guiana
Completed NCT05531929 - Role of Anxio-depressive History on Return to Work and Sport After Rotator Cuff Surgery
Enrolling by invitation NCT04662021 - Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety N/A